Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 8

1.

Effects of NMDA antagonists on ethanol-withdrawal induced "anxiety" in the elevated plus maze.

Gatch MB, Wallis CJ, Lal H.

Alcohol. 1999 Nov;19(3):207-11.

PMID:
10580509
[PubMed - indexed for MEDLINE]
2.

Anxiety-like behaviors following chronic ethanol exposure.

Kliethermes CL.

Neurosci Biobehav Rev. 2005 Jan;28(8):837-50. Epub 2004 Dec 10. Review.

PMID:
15642625
[PubMed - indexed for MEDLINE]
3.

The NR2B subtype of NMDA receptor: a potential target for the treatment of alcohol dependence.

Nagy J.

Curr Drug Targets CNS Neurol Disord. 2004 Jun;3(3):169-79. Review.

PMID:
15180478
[PubMed - indexed for MEDLINE]
4.

Alcohol withdrawal: a review of clinical management.

Castaneda R, Cushman P.

J Clin Psychiatry. 1989 Aug;50(8):278-84. Review.

PMID:
2569456
[PubMed - indexed for MEDLINE]
5.

Management of alcohol withdrawal: treatment controversies.

Engle JP, Leoni JM, Donnelly AJ.

Am Pharm. 1988 Nov;NS28(11):51-7. Review. No abstract available.

PMID:
2905112
[PubMed - indexed for MEDLINE]
6.

Antianxiety drugs in alcohol withdrawal.

Sellers EM.

Curr Psychiatr Ther. 1978;18:157-63. Review. No abstract available.

PMID:
38064
[PubMed - indexed for MEDLINE]
7.

Psychopharmacology in supportive care in cancer: a review for the clinician. I. Benzodiazepines.

Stiefel F, Berney A, Mazzocato C.

Support Care Cancer. 1999 Nov;7(6):379-85. Review.

PMID:
10541978
[PubMed - indexed for MEDLINE]
8.

Kynurenines and anxiety.

Lapin IP.

Adv Exp Med Biol. 1996;398:191-4. Review. No abstract available.

PMID:
8906265
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk